⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 1, 1935Journal of Clinical InvestigationOpen Access

Dietary Protein in Hemorrhagic Bright's Disease

E. Henry Keutmann Samuel H. Bassett Geraldine E. Julian Clara H. Present Helen E. Van Alstine

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Protein supplements. With one exception, which is discussed under the case of L. R., the protein supplements

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Keutmann et al. (1935) studied this question.

synapsesocial.com/papers/6a706033e71d69abee089002 https://doi.org/10.1172/jci100737

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Synthetic immunological niche reveals early immune dysregulation and stratifies therapeutic response in type 1 diabetesJournal of Clinical Investigation · 2026
2Biological sex-dependent hormonal signaling and metabolomic profiles in obesity alter tumor microenvironment and immunotherapy outcomesJournal of Clinical Investigation · 2026
3Cerebellar and frontal lobe alterations in pulmonary hypertension implicate an inflammatory lung vascular/brain axisJournal of Clinical Investigation · 2026
4Dapagliflozin attenuates progression from prefrailty to frailty in patients with hypertension and chronic kidney diseaseJournal of Clinical Investigation · 2026
5Targeting N-acetyltransferase 10 reprograms Treg function to enhance anti–PD-1 immunotherapy sensitivity in murine lung tumorsJournal of Clinical Investigation · 2026
6Nuclear cGAS governs transcription to control lipid metabolism, tumor growth, and therapy responseJournal of Clinical Investigation · 2026
7A rare TMEM175 mutation drives Parkinson’s disease pathology by disrupting proton gating and lysosomal acidificationJournal of Clinical Investigation · 2026
8TARBP2 facilitates renal cell carcinoma immune escape by suppressing 53BP1 phase separation to upregulate B7-H3Journal of Clinical Investigation · 2026
9Neoadjuvant PD-L1/TGF-β blockade can rapidly disrupt the tumor stroma in head and neck cancer patientsJournal of Clinical Investigation · 2026
10B cells and the therapeutic index of checkpoint blockadeJournal of Clinical Investigation · 2026

More from Journal of Clinical Investigation

More from University of Rochester

More from Strong Memorial Hospital